Palliative care in castrate-resistant prostate cancer - PubMed (original) (raw)

Review

. 2012 Nov;39(4):491-503.

doi: 10.1016/j.ucl.2012.07.006. Epub 2012 Aug 27.

Affiliations

Review

Palliative care in castrate-resistant prostate cancer

Michael W Rabow et al. Urol Clin North Am. 2012 Nov.

Abstract

Significant symptoms and suffering related to castrate-resistant prostate cancer (CRPC) are associated with the disease and its treatment. Increasingly, with advances in treatment efficacy, men can live with symptoms for long periods. Interdisciplinary palliative care teams (including physicians, nurses, social workers, chaplains, pharmacists, psychologists, physical therapists, and nutritionists) focused on symptom management and patients' goals of care can collaborate with prostate cancer surgeons, oncologists, and radiation oncologists to provide the best care for men at all stages of treatment, including end of life. This article reviews the benefits of palliative care in helping patients with CRPC manage symptoms and distress.

Copyright © 2012 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources